RPRX
RPRX
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
3
$23.79M
Total Volume
$23.79M
37 transactions
Net Activity
$23.79M
Net selling
Sentiment Rating
Moderate DistributionCEO Conviction Index
No Recent Signal
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Coyne Terrance P.
EVP, CFO
$17.69M total
Hite Christopher
EVP, COB, Partnering
$5.85M total
Urist Marshall
EVP, Research, Investments
$239K total
Multiple Insiders
S - Sale Insiders
$0 total
Quick Actions
RPRX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. RPRX ranks #96 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at RPRX (RPRX) engaged in a total of 37 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $23.79M.
The net insider activity for RPRX shows a net selling bias of $23.79M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Coyne Terrance P. (EVP, CFO), who traded 257.1K shares valued at $17.69M on Nov 16, 2026.
Royalty Pharma plc (RPRX) stock price, news, quote and history
RPRX - Royalty Pharma plc Stock Price and Quote
Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run
Royalty Pharma PLC $RPRX Stock: Danske Bank A S Grows Position
Royalty Pharma (RPRX) Stock Looks Above Fair Value Despite Royalty Portfolio Focus
symbol__ Stock Quote Price and Forecast
FAQs About RPRX Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for RPRX.